DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,492,000 | -16.8% | 5,887 | -7.9% | 0.11% | +390.9% |
| Q1 2022 | $1,794,000 | -12.8% | 6,392 | +2.2% | 0.02% | -83.8% |
| Q4 2021 | $2,058,000 | +19.3% | 6,256 | +10.4% | 0.14% | +14.3% |
| Q3 2021 | $1,725,000 | +40.5% | 5,665 | +23.8% | 0.12% | +38.4% |
| Q2 2021 | $1,228,000 | +63.1% | 4,576 | +36.7% | 0.09% | +48.3% |
| Q1 2021 | $753,000 | +0.3% | 3,347 | -1.0% | 0.06% | -4.9% |
| Q4 2020 | $751,000 | -5.8% | 3,380 | -8.7% | 0.06% | -16.4% |
| Q3 2020 | $797,000 | +31.5% | 3,701 | +8.0% | 0.07% | +30.4% |
| Q2 2020 | $606,000 | +54.6% | 3,427 | +21.1% | 0.06% | -12.5% |
| Q1 2020 | $392,000 | -0.5% | 2,830 | +10.3% | 0.06% | +1.6% |
| Q4 2019 | $394,000 | -10.9% | 2,565 | -16.2% | 0.06% | -3.1% |
| Q3 2019 | $442,000 | +11.9% | 3,061 | +10.9% | 0.06% | +12.1% |
| Q2 2019 | $395,000 | -0.3% | 2,761 | -8.0% | 0.06% | +7.4% |
| Q1 2019 | $396,000 | +27.3% | 3,000 | -0.6% | 0.05% | +14.9% |
| Q4 2018 | $311,000 | -3.4% | 3,018 | +1.9% | 0.05% | +51.6% |
| Q3 2018 | $322,000 | +31.4% | 2,961 | +19.2% | 0.03% | -11.4% |
| Q2 2018 | $245,000 | -6.1% | 2,484 | -18.3% | 0.04% | -7.9% |
| Q3 2017 | $261,000 | -12.1% | 3,039 | -13.7% | 0.04% | -15.6% |
| Q2 2017 | $297,000 | -1.3% | 3,523 | 0.0% | 0.04% | -2.2% |
| Q1 2017 | $301,000 | +6.0% | 3,523 | -3.6% | 0.05% | 0.0% |
| Q4 2016 | $284,000 | -17.7% | 3,653 | -17.0% | 0.05% | -11.5% |
| Q3 2016 | $345,000 | -22.5% | 4,403 | 0.0% | 0.05% | -26.8% |
| Q2 2016 | $445,000 | +6.5% | 4,403 | 0.0% | 0.07% | +102.9% |
| Q1 2016 | $418,000 | +5.0% | 4,403 | +2.8% | 0.04% | -45.3% |
| Q4 2015 | $398,000 | +23.6% | 4,283 | +13.2% | 0.06% | +25.5% |
| Q3 2015 | $322,000 | +12.2% | 3,783 | +12.9% | 0.05% | +15.9% |
| Q2 2015 | $287,000 | +29.9% | 3,350 | +28.8% | 0.04% | +25.7% |
| Q1 2015 | $221,000 | -0.9% | 2,600 | 0.0% | 0.04% | -16.7% |
| Q4 2014 | $223,000 | – | 2,600 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |